We are live on ! Find out more
MCAV

Meritech Capital Associates V Portfolio holdings

AUM $141M
1-Year Est. Return 15.44%
This Fund
S&P 500
This Quarter Est. Return
-20.43%
1 Year Est. Return
+15.44%
3 Year Est. Return
+37.35%
5 Year Est. Return
+8.8%
10 Year Est. Return
AUM
$314M
AUM Growth
-$103M
Cap. Flow
-$13.3M
Cap. Flow %
-4.24%
Top 10 Hldgs %
100%
Holding
6
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
TXG icon
10x Genomics
TXG
+$13.3M

Sector Composition

Rank Sector Weight
1 Communication Services 60.85%
2 Technology 32.66%
3 Healthcare 6.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RBLX icon
1
Roblox
RBLX
$25.7B
$187M 59.56%
6,465,782
DDOG icon
2
Datadog
DDOG
$81.6B
$85.5M 27.19%
938,437
TXG icon
3
10x Genomics
TXG
$5.79B
$20.4M 6.49%
494,236
-256,266
-34% -$13.3M
AMPL icon
4
Amplitude
AMPL
$1.43B
$8.88M 2.83%
767,617
OKTA icon
5
Okta
OKTA
$24.9B
$8.32M 2.65%
102,100
NXDR
6
Nextdoor Holdings
NXDR
$983M
$4.04M 1.29%
2,219,811

Similar funds

Meritech Capital Associates V's Q3 2023 Portfolio in Review

As of Q3 2023, Meritech Capital Associates V held 6 positions worth $314M, down 25% from $418M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Meritech Capital Associates V withdrew a net $13.3M in Q3 2023, reducing 1 holding. Its largest reduction was 10x Genomics, cutting an estimated $13.3M.

By sector, the portfolio is most concentrated in Communication Services at 61% of assets, down from 64% a quarter earlier, followed by Technology and Healthcare.

  • Meritech Capital Associates V's biggest Q3 2023 reduction was 10x Genomics, cutting an estimated $13.3M.
  • Meritech Capital Associates V's ten largest holdings make up 100% of its $314M portfolio in Q3 2023.
  • Meritech Capital Associates V opened 0 new positions and closed 0 in Q3 2023.
  • Meritech Capital Associates V's portfolio value fell 25% quarter-over-quarter to $314M.

Based on Meritech Capital Associates V's 13F filing for Q3 2023, filed 14 Nov 2023.